Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort study
Yasuaki Takeji(Kanazawa University), Takeshi Kimura(Municipal Hirakata City Hospital), Yukiko Mutsumura-Nakano(Kyoto University), Hidenori Yaku(Kyoto University), Masayuki Fuki(Tenri Hospital), Ryoji Taniguchi(Hyogo Prefectural Amagasaki General Medical Center), Yukihito Sato(Hyogo Prefectural Amagasaki General Medical Center), Hiroki Watanabe(Kyoto University), Tatsuhiko Komiya(Kurashiki Central Hospital), Natsuhiko Ehara(Kyoto University Hospital), Yugo Yamashita(Kyoto University Hospital), Manabu Shirotani(Hyogo Medical University), Junichi Tazaki(Hyogo Medical University), Eiji Shinoda(Hyogo Medical University), Kenji Minatoya(National Cerebral and Cardiovascular Center), Yutaka Furukawa(Kobe City Medical Center General Hospital), Kenji Andò(Kokura Memorial Hospital), Erika Yamamoto(Kyoto University), Yusuke Yoshikawa(Kyoto University), Hiroki Shiomi(Kyoto University), Yoshiharu Soga(Kokura Memorial Hospital), Hirotoshi Watanabe(Municipal Hirakata City Hospital), Ko Yamamoto(Kyoto University), Satoru Suwa(Juntendo University Shizuoka Hospital), Moriaki Inoko(Hyogo Medical University), Tomoya Onodera(Shizuoka City Hospital), Katsuhisa Ishii(Hyogo Medical University), Kenji Nakatsuma(Kyoto University), Kazushige Kadota(Kurashiki Central Hospital), Takashi Yamamoto(Koga Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Tsukasa Inada(Osaka Red Cross Hospital), Toshihiro Tamura(Tenri Hospital), Teruki Takeda(Hyogo Medical University), Eri Kato(Kyoto University Hospital), Hiroki Sakamoto(Kokura Memorial Hospital), Kyohei Yamaji(Kokura Memorial Hospital)
Cited by 11
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
|The Lancet Diabetes & Endocrinology|2019|673
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507